APVO (Aptevo Therapeutics, Inc.) Bozor qiymatining balans qiymatiga nisbati
Yirik hamkorlar bilan hamkorlikda qattiq va gematologik o'smalarga qarshi kurashish uchun antitanachalar ishlab chiqish Aptevo Therapeutics (APVO) uchun xarajatlarni minimallashtiradi. Joriy bozor qiymatining buxgalteriya qiymatiga nisbati tebranishlarni namoyish etmoqda, bunda 0.30 qiymati joriy darajani tavsiflaydi. Immunologiyadagi ADAPTIR platformasining texnologik yutug'i kompaniyaning o'tkir likvidlik tanqisligi va ortib borayotgan qarz yukiga zid keladi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_APVO_-_Aptevo-Therapeutics_-_Market-Capitalization-to-Net-Assets "APVO Aptevo Therapeutics Inc. Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Aptevo Therapeutics (APVO) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Aptevo Therapeutics|APVO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati aptevotherapeutics.com|APVO - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Aptevo|APVO - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Aptevo Therapeutics
Kompaniyaning dastlabki tahlili:Aptevo Therapeutics, Inc. - APVO
Aptevo Therapeutics kompaniyasining antitelalarni ishlab chiqish jarayoni yuqori intellektual kapital xarajatlarini talab qiladi, bu esa GURU.Markets platformasidagi kompaniyaning nisbiy kapitalizatsiya ko'rsatkichi bilan ifodalanadi. Ushbu ko'rsatkich emitentning bozor qiymatini uning balans qiymati bilan solishtiradi. Ko'rsatkich sof aktivlardan yuqori bo'lgan bozor premiumini o'lchab, biznesning yetuklik darajasini aniqlaydi. Barqaror R&D tarkibi operatsion xatarlarni minimallashtirib, fundamental qiymatni qo'llab-quvvatlaydi. Investorlar ushbu ko'paytiruvchining keskin va impulsiv o'sishlari paytida sotib olishdan qochishlari lozim.
Asosiy raqobatchilar
Bozor qiymatining balans qiymatiga nisbati ARGX|BNTX (biontech.de) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|Rigel Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|ANAB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Astria Therapeutics (ATXS)|Sof aktivlarga nisbatan bozor kapitallashuvi engene.com|RAPT Therapeutics (RAPT) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Aerovate|Aclaris - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Kyverna Therapeutics, Inc KYTX|Kapitallashuvning sof aktivlarga nisbati Tiziana Life Sciences TLSA|cabalettabio.com - Bozor qiymatining balans qiymatiga nisbati|VTYX (Ventyx Biosciences, Inc.) - Bozor qiymatining balans qiymatiga nisbati|Theratechnologies, Inc. (THTX) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Avalo Therapeutics Inc. AVTX|Balans qiymatiga nisbatan bozor qiymati Eledon Pharmaceuticals, Inc|Agenus (AGEN) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori climbbio.com|Zura Bio (ZURA) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati aTyr Pharma Inc (ATYR)|ADAG: Bozor kapitallashuvining balans qiymatiga nisbati|ImageneBio - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Shattuck Therapeutics (STTK)|EQ - Balans qiymatiga nisbatan bozor qiymati|CNTB: Bozor kapitallashuvining balans qiymatiga nisbati|IMUX (Immunic) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Atara Biotherapeutics, Inc. ATRA|Sof aktivlarga nisbatan bozor kapitallashuvi InflaRx GmbH|X4 Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti adicetbio.com ACET|Kapitallashuvning sof aktivlarga nisbati CELU (Celularity)|INMB - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Barinthus Bio BRNS|KZR - Bozor kapitallashuvining balans qiymatiga multiplikatori|SAB Biotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|akaritx.com (AKTX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ENLV|Kapitallashuvning sof aktivlarga nisbati QTTB|GOVX (GeoVax Labs Inc) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Edesa Biotech Corp (EDSA)|Bozor kapitallashuvining balans qiymatiga nisbati IBIO (iBio, Inc.)|Carisma Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati XTL Biopharmaceuticals Ltd.|Bolt Biotherapeutics (BOLT) - Sof aktivlarga nisbatan bozor kapitallashuvi|hcwbiologics.com (HCWB) - Kapitallashuvning sof aktivlarga nisbati|AIM (aimimmuno.com) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati ADTX (Aditxt Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti GRI|XRTX - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Vyome Holdings Inc. (HIND)|Bozor kapitallashuvining balans qiymatiga nisbati Revelation Bio|Balans qiymatiga nisbatan bozor qiymati Indaptus Corp INDP|Scinai Immunotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|CALI: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati affimed.com AFMD|ALLK (Allakos) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HOOK|Kapitallashuvning sof aktivlarga nisbati IGM Bio|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|Bozor kapitallashuvining balans qiymatiga nisbati oceanbiomedical.com OCEA|Kapitallashuvning sof aktivlarga nisbati TC BioPharm|Balans qiymatiga nisbatan bozor qiymati Third Harmonic Bio Inc. THRD